Find Military Health Affairs and Defense Health Agency policy documents.
If you're having trouble finding what you're looking for, consider using fewer words in your search criteria. Results are limited to content that matches all terms in the search field.
We found - potentially matching ""
Advanced Search Options
This memorandum directs all Military Treatment Facility (MTF) and Dental Treatment Facility (DTF) Commanders and Directors to immediately postpone all elective surgeries, invasive procedures, and dental procedures performed on beneficiaries of the MTFs and DTFs with the exceptions outlined below. This includes aerosol-producing procedures, such as endoscopies, bronchoscopies, pulmonary function tests, and sleep continuous positive airway pressure (CPAP) titrations. This policy is effective March 31, 2020, and will remain in place for 60 days.
This Defense Health Agency-Interim Procedures Memorandum (DHA-IPM), establishes the Defense Health Agency’s (DHA) procedures to implement instructions, assign responsibilities, and prescribe procedures for the Southern Hemisphere Influenza Vaccination Program. All Active Duty, Selected Reserve, and National Guard members receive an annual influenza vaccination. Personnel who are traveling to, conducting a permanent change of station to, or are located in the Southern Hemisphere will receive the Southern Hemisphere influenza vaccine or obtain an exemption (e.g., medical or administrative) in accordance with guidance in paragraph 6.a. of Attachment 2. Military personnel residing in the Southern Hemisphere who have received the Southern Hemisphere influenza vaccine in accordance with Appendix 1, meet the annual influenza immunization requirement.
This DHA-PI establishes Defense Health Agency’s (DHA) procedures to provide key stakeholders’ responsibilities for connecting medical devices to MHS GENESIS; establish clinical expectations for connecting medical devices to MHS GENESIS; provide references for MTFs to use in procuring medical devices that will be connected to MHS GENESIS; and provide process for MTFs to elevate medical device connection issues related to MHS GENESIS.
This DHA-PI ensures alignment of the Integrated Capabilities Portfolio (ICP) process with the National Military Strategy, support the Quadruple Aim , and ensure every resource is supporting the critical initiatives of the DHA. This effort ensures that every dollar spent provides value back to the Military Health System (MHS), improves efficiency and effectiveness, and supports readiness and health.
This DHA-PI establishes centralized processes and procedures to implement and maintain RMF authorization and cybersecurity for MDE across the Military Health System (MHS) through the Defense Health Agency (DHA) CyberLOG. This DHA-PI develops the standard DHA cybersecurity requirements process to translate and identify MTFs MDE planning requirements; implements a standard cybersecurity approach to analyze, evaluate, and manage MDE planning, procurement, and sustainment to meet cybersecurity requirements through the RMF process; executes the DHA RMF authorization process within DHA activities for MDE purchased with DHP funds; and maintains an acceptable security baseline for MDE.
This Defense Health Agency-Procedural Instruction (DHA-PI), provides procedures for implementing uniform accountability and business rules for communicating clinical laboratory and radiology results. This DHA-PI establishes uniform processes, measures, workflows, and business rules which include documentation requirements and performance metrics for standardized notification of patients (or personal representatives), of laboratory and radiology results.
This Defense Health Agency-Procedural Instruction (DHA-PI), establishes the Defense Health Agency’s (DHA) procedures to remove erroneously entered information in the EHRs. In general, these procedures should be limited to Personally Identifiable Information (PII) or Protected Health Information (PHI) pertaining to one person or persons, but entered inadvertently into the record of a different person. These procedures may also be applied to other information (e.g., incorrect adverse diagnosis), as deemed necessary after appropriate review. All efforts to correct documentation errors at the user level should be expended prior to requesting a correction. Patient-initiated requests to correct the EHR must be completed within 60 days of the request being received by the covered entity (the Military Medical Treatment Facility (MTF)), or 90 days if applicable extension requirements are met.
The purpose of this DHA-PI is to comply with Presidential Memorandum for the Heads of Executive Departments and Agencies, to support the clinical practice of acupuncture by designated clinical staff throughout the DoD, as a complement to existing pharmacologic and non-pharmacologic therapies. This DHA-PI establishes the DHA’s procedures to expand the availability and utilization of acupuncture as a non-pharmacologic therapy for acute and chronic pain as an essential element of the Military Health Service (MHS) Pain Management Campaign.
The purpose of this DHA-PI is to notify and instruct stakeholders across the MHS of the newly integrated MHS Request Submissions Portal and submissions process approved by Director, DHA, launched on October 1, 2018. The MHS Request Submissions Portal can be found at the following location: https://info.health.mil/SitePages/mhsCAR_submit.aspx. This DHA-PI aligns to National Military Strategy as a Combat Support Agency (CSA), to achieve the Quadruple Aim and ensure every resource is supporting the critical initiatives of the DHA, Combatant Commanders (CCMDs), Military Departments, and Military Medical Treatment Facilities (MTFs).
DTM 20-001 - Policy Revisions for the Disability Evaluation System
DODI 2310.09 has been added.
DODI 6000.19 - Military Treatment Facility Support of Medical Readiness Skills of Readiness Skills of Health Care Providers
DoDI 6000.19 Military Medical Treatment Facility Support of Medical Readiness Skills of Health Care Providers
DODI 6000.19 has been added.
DHA Address: 7700 Arlington Boulevard | Suite 5101 | Falls Church, VA | 22042-5101
The appearance of hyperlinks does not constitute endorsement by the Defense Health Agency of non-U.S. Government sites or the information, products, or services contained therein. Although the Defense Health Agency may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all of the information that you may find at these locations. Such links are provided consistent with the stated purpose of this website.